Balance Sheet

Assets

+2%

+15%

10Y

Currency: JPY

	Feb-2002	Feb-2003	Feb-2004	Feb-2005	Feb-2006	Feb-2007	Feb-2008	Feb-2009	Feb-2010	Feb-2011	Feb-2012	Feb-2013	Feb-2014	Feb-2015	Feb-2016	Feb-2017	Feb-2018	Feb-2019	Feb-2020	Feb-2021	Feb-2022	Feb-2023	Feb-2024	Feb-2025
Assets
Cash & Cash Equivalents	12 881	14 340	17 379	31 105	36 579	29 817	36 129	39 354	26 935	33 186	27 789	41 157	66 307	71 298	81 584	80 280	117 189	110 283	107 051	114 254	129 290	122 154	112 459	114 518
Cash Equivalents	12 881	14 340	17 379	31 105	36 579	29 817	36 129	39 354	26 935	33 186	27 789	41 157	66 307	71 298	81 584	80 280	117 189	110 283	107 051	114 254	129 290	122 154	112 459	114 518
Short-Term Investments	876	2 048	501	1 174	849	3 111	2 332	4 169	0	5 380	7 083	12 338	15 453	25 192	30 895	32 767	14 759	20 946	34 878	21 743	13 141	14 714	12 862	14 598
Total Receivables	17 295	17 375	22 312	19 796	23 692	28 230	31 136	39 198	42 057	36 619	33 433	36 775	36 837	46 252	37 355	35 772	34 946	39 662	48 907	39 203	38 112	39 753	42 983	46 879
Accounts Receivables	17 295	17 375	22 312	19 796	23 692	28 230	31 136	39 198	42 057	36 619	33 433	36 775	36 837	46 252	37 355	35 772	34 946	39 662	48 907	39 203	38 112	39 753	42 983	46 879
Other Receivables	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Inventory	4 573	5 195	5 191	5 836	8 526	8 931	8 635	9 180	12 271	11 301	12 551	13 328	15 196	15 450	15 915	17 687	16 970	15 758	15 458	18 568	16 412	18 922	21 176	22 391
Other Current Assets	1 796	2 453	2 564	3 170	4 911	2 374	2 254	3 108	4 835	6 406	6 598	4 121	5 314	7 123	6 011	5 591	6 201	4 769	2 957	4 293	3 221	3 631	4 542	5 402
Total Current Assets	37 421	41 411	47 947	61 081	74 557	72 463	80 486	95 009	86 098	92 892	87 454	107 719	139 107	165 315	171 760	172 097	190 065	191 418	209 251	198 061	200 176	199 174	194 022	203 788
PP&E Net	33 960	37 163	36 619	35 168	36 168	38 496	40 298	40 325	46 218	44 259	43 356	43 219	43 330	45 003	43 851	43 031	40 064	39 556	38 596	37 354	39 069	43 209	49 462	59 899
PP&E Gross	33 960	37 163	36 619	35 168	36 168	38 496	40 298	40 325	46 218	44 259	43 356	43 219	43 330	45 003	43 851	43 031	40 064	39 556	38 596	37 354	39 069	43 209	49 462	59 899
Accumulated Depreciation	28 629	31 417	33 710	36 260	38 248	39 854	40 640	43 913	48 155	52 565	52 751	56 203	59 296	59 296	65 415	67 954	71 013	73 220	75 551	77 660	80 359	83 459	87 306	89 993
Intangible Assets	624	467	349	316	230	72	1 247	2 736	7 852	6 672	11 261	12 051	11 532	11 355	8 617	5 973	4 100	1 990	1 469	1 178	1 326	946	5 387	4 680
Goodwill	0	0	0	0	8 528	6 331	4 216	2 102	7 902	6 268	5 286	5 112	5 280	0	3 905	0	0	0	0	0	0	0	1 444	1 294
Note Receivable	0	0	0	1 414	800	855	512	361	62	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Long-Term Investments	7 095	6 012	7 642	9 504	13 767	17 935	14 872	13 465	31 979	31 799	34 549	36 685	42 947	48 779	48 234	49 989	57 169	53 521	48 379	54 602	52 519	60 845	67 121	60 222
Other Long-Term Assets	3 787	4 320	4 656	3 573	2 527	4 984	8 111	13 640	13 433	12 886	10 922	9 355	9 656	10 040	8 587	7 730	8 515	9 301	9 706	8 666	9 768	9 743	11 343	13 185
Other Assets	0	0	0	0	8 528	6 331	4 216	2 102	7 902	6 268	5 286	5 112	5 280	0	3 905	0	0	0	0	0	0	0	1 444	1 294
Total Assets	82 887 N/A	89 373 +8%	97 213 +9%	111 056 +14%	136 577 +23%	141 136 +3%	149 742 +6%	167 638 +12%	193 544 +15%	194 776 +1%	192 828 -1%	214 141 +11%	251 852 +18%	285 440 +13%	284 954 0%	278 820 -2%	299 913 +8%	295 786 -1%	307 401 +4%	299 861 -2%	302 858 +1%	313 917 +4%	328 779 +5%	343 068 +4%
Liabilities
Accounts Payable	8 356	7 706	7 909	7 554	10 129	9 004	9 933	13 062	14 669	11 279	11 932	12 991	14 612	17 851	14 016	14 380	13 911	14 154	19 024	14 799	13 225	14 918	16 263	14 115
Accrued Liabilities	481	499	515	493	617	688	808	844	1 381	1 499	1 550	1 714	1 942	2 249	1 940	1 708	1 674	1 629	1 558	1 350	1 363	1 340	1 831	2 213
Short-Term Debt	0	0	0	0	0	0	0	0	0	0	0	0	1 540	1 560	1 605	1 490	1 390	1 290	1 140	1 040	1 000	1 000	1 000	1 000
Current Portion of Long-Term Debt	1 574	689	1 389	1 629	5 822	3 467	1 038	1 047	10 519	6 158	4 555	1 799	249	249	111	93	100	97	137	172	372	398	421	474
Other Current Liabilities	9 635	12 698	10 056	12 607	17 606	14 756	15 824	19 691	16 252	20 336	13 091	17 881	23 402	22 412	23 325	14 754	17 863	13 184	19 196	12 696	16 200	24 922	26 423	29 424
Total Current Liabilities	20 046	21 592	19 869	22 283	34 174	27 915	27 603	34 644	42 821	39 272	31 128	34 385	41 745	44 299	40 997	32 425	34 938	30 354	41 055	30 057	32 160	42 578	45 938	47 226
Long-Term Debt	1 352	1 612	1 505	1 373	3 549	1 058	842	881	8 287	3 464	1 528	1 234	1 008	788	689	608	568	503	498	390	1 088	897	679	2 382
Deferred Income Tax	1 954	1 954	1 893	1 887	1 887	2 579	2 164	2 164	5 191	4 132	3 389	2 286	3 775	3 775	5 730	5 525	7 823	5 222	2 978	5 125	4 170	1 813	4 518	4 304
Minority Interest	480	476	668	698	744	735	750	719	889	930	1 036	747	865	1 031	1 000	1 097	1 227	1 295	1 470	1 510	1 717	2 042	2 205	2 581
Other Liabilities	3 581	3 507	3 825	3 946	5 704	5 618	5 208	5 843	6 268	6 689	7 522	8 303	9 016	11 050	11 443	11 057	11 357	11 078	12 124	10 480	10 555	10 221	10 562	9 749
Total Liabilities	27 413 N/A	29 141 +6%	27 760 -5%	30 187 +9%	46 058 +53%	37 905 -18%	36 567 -4%	44 251 +21%	63 456 +43%	54 487 -14%	44 603 -18%	46 955 +5%	56 409 +20%	64 417 +14%	59 859 -7%	50 712 -15%	55 913 +10%	48 452 -13%	58 125 +20%	47 562 -18%	49 690 +4%	57 551 +16%	63 902 +11%	66 242 +4%
Equity
Common Stock	8 473	8 473	8 473	8 473	8 473	8 473	8 473	8 473	8 473	8 473	8 473	8 473	8 473	8 473	8 473	8 473	8 473	8 473	8 473	8 473	8 473	8 473	8 473	8 473
Retained Earnings	41 704	50 198	59 922	71 484	84 240	95 325	109 198	122 838	135 486	150 461	163 136	172 488	187 846	199 990	210 826	224 417	236 641	249 548	231 420	233 608	236 446	235 829	242 912	258 289
Additional Paid In Capital	8 241	8 241	8 241	8 241	8 289	8 376	8 396	8 396	8 396	8 396	8 396	8 396	8 396	8 396	8 396	5 914	5 914	5 914	2 272	2 352	2 356	2 361	2 361	2 361
Unrealized Security Profit/Loss	42	389	1 084	1 066	2 858	4 248	326	2 154	780	564	47	5 634	10 070	16 546	17 004	18 216	22 915	20 799	15 837	19 955	18 711	20 445	25 455	21 822
Treasury Stock	2 542	5 537	7 232	7 282	12 506	12 501	12 504	12 571	18 521	18 525	21 844	21 846	21 851	21 854	26 033	34 705	34 709	40 886	11 730	11 495	19 527	27 196	36 993	47 550
Other Equity	361	756	1 037	1 115	836	692	712	1 596	2 968	7 949	9 983	5 959	2 509	9 472	6 429	5 793	4 766	3 486	3 004	594	6 709	16 454	22 669	33 431
Total Equity	55 473 N/A	60 230 +9%	69 451 +15%	80 867 +16%	90 518 +12%	103 229 +14%	113 177 +10%	123 386 +9%	130 086 +5%	140 292 +8%	148 225 +6%	167 186 +13%	195 443 +17%	221 023 +13%	225 095 +2%	228 108 +1%	244 000 +7%	247 334 +1%	249 276 +1%	252 299 +1%	253 168 +0%	256 366 +1%	264 877 +3%	276 826 +5%
Total Liabilities & Equity	82 886 N/A	89 371 +8%	97 211 +9%	111 054 +14%	136 576 +23%	141 134 +3%	149 744 +6%	167 637 +12%	193 542 +15%	194 779 +1%	192 828 -1%	214 141 +11%	251 852 +18%	285 440 +13%	284 954 0%	278 820 -2%	299 913 +8%	295 786 -1%	307 401 +4%	299 861 -2%	302 858 +1%	313 917 +4%	328 779 +5%	343 068 +4%
Shares Outstanding
Common Shares Outstanding	94	92	91	91	89	89	89	89	87	87	86	86	86	86	85	84	84	83	82	82	80	78	76	73

Income Statement Balance Sheet Cash Flow Statement

Hisamitsu Pharmaceutical Co Inc
TSE:4530

Balance Sheet

Balance Sheet Decomposition
Hisamitsu Pharmaceutical Co Inc

Balance Sheet
Hisamitsu Pharmaceutical Co Inc

See Also

Company

Help

Tools

Stocks

Hisamitsu Pharmaceutical Co Inc TSE:4530

Balance Sheet

Balance Sheet Decomposition Hisamitsu Pharmaceutical Co Inc

Balance Sheet Hisamitsu Pharmaceutical Co Inc

See Also

Company

Help

Tools

Stocks

Hisamitsu Pharmaceutical Co Inc
TSE:4530

Balance Sheet Decomposition
Hisamitsu Pharmaceutical Co Inc

Balance Sheet
Hisamitsu Pharmaceutical Co Inc